Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.jconrel.2012.08.032
Title: Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy
Authors: Xu, Q.
Xia, Y.
Wang, C.-H. 
Pack, D.W.
Keywords: Chitosan
Double-walled microspheres
Doxorubicin
Gene therapy
p53
PLGA
Issue Date: 28-Oct-2012
Citation: Xu, Q., Xia, Y., Wang, C.-H., Pack, D.W. (2012-10-28). Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy. Journal of Controlled Release 163 (2) : 130-135. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jconrel.2012.08.032
Abstract: We have designed and evaluated a dual anticancer delivery system to provide combined gene therapy and chemotherapy. Double-walled microspheres consisting of a poly(d,l-lactic-co-glycolic acid) (PLGA) core surrounded by a poly(lactic acid) (PLA) shell were fabricated via the precision particle fabrication (PPF) technique. We make use of the advantages of double-walled microspheres to deliver chitosan-DNA nanoparticles containing the gene encoding the p53 tumor suppressor protein (chi-p53) and/or doxorubicin (Dox), loaded in the shell and core phases, respectively. Different molecular weights of PLA were used to form the shell layer for each formulation. The microspheres were monodisperse with a mean diameter of 65 to 75 μm and uniform shell thickness of 8 to 17 μm. Blank and Dox-loaded microspheres typically exhibited a smooth surface with relatively few small pores, while chi-microspheres containing p53 nanoparticles, with and without Dox, presented rough and porous surfaces. The encapsulation efficiency of Dox was significantly higher when it was encapsulated alone compared to co-encapsulation with chi-p53 nanoparticles. The encapsulation efficiency of chi-p53 nanoparticles, on the other hand, was not affected by the presence of Dox. As desired, chi-p53 nanoparticles were released first, followed by simultaneous release of chi-p53 nanoparticles and Dox at a near zero-order rate. Thus, we have demonstrated that the PPF method is capable of producing double-walled microspheres and encapsulating dual agents for combined modality treatment, such as gene therapy and chemotherapy. © 2012 Elsevier B.V.
Source Title: Journal of Controlled Release
URI: http://scholarbank.nus.edu.sg/handle/10635/89493
ISSN: 01683659
DOI: 10.1016/j.jconrel.2012.08.032
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

40
checked on Apr 5, 2020

WEB OF SCIENCETM
Citations

40
checked on Mar 20, 2020

Page view(s)

65
checked on Mar 29, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.